Results 81 to 90 of about 13,185 (147)

Beyond target engagement: RNA therapeutics and the neuroimmune challenge in tauopathies. [PDF]

J Prev Alzheimers Dis
Breen EA.
europepmc   +1 more source

RNA-based therapeutics for Alzheimer's disease and related tauopathies: challenges and opportunities. [PDF]

J Prev Alzheimers Dis
Rajbanshi B, Brentari I, Denti MA, Cummings JL, Guruacharya A.   +4 more
europepmc   +1 more source

Olfactory dysfunction as a marker of neurodegenerative disease in older adults. [PDF]

Aging Clin Exp Res
Klíčová K, Menšíková K, Šebelová D, Polčáková P, Kaleta M, Cook SEV, Ildžová Z, Satke L, Zimek D, Kaňovský P.   +9 more
europepmc   +1 more source

From Food Additives to Neurodegeneration: The Emerging Role of Polyphosphates in Tauopathies. [PDF]

ACS Chem Neurosci
Barolo L, Farina MV, Cimaglia G, Gigante Y, Mirone A, Mautone L, Boffi A, Di Angelantonio S, Baiocco P.   +8 more
europepmc   +1 more source

Editorial: In celebration of women in science: Structural biology

Frontiers in Molecular Biosciences, 2023
Roberta Spadaccini
doaj   +1 more source

Tau profiling of brain extracellular vesicles reveals PHF6 peptide as core for pathological tau seeding in Alzheimer's disease. [PDF]

J Biomed Sci
Oosterlynck M, Fichter L, Leroux E, Eddarkaoui S, Bouillet T, Lefebvre C, Nguyen M, Maurage CA, Accart B, Dupré E, Landrieu I, Danis C, Lehmann S, Vialaret J, Buée L, Hirtz C, Colin M.   +16 more
europepmc   +1 more source

Emerging directions in tauopathy research. [PDF]

Alzheimers Dement
Buée L, Wildsmith KR, Alladi S, Bertucci T, Boche D, Bowles KR, Boxer A, Brummet J, DeVos SL, Diaz K, Dreyer AJ, Duff K, Duran-Aniotz C, Durrant CS, Farrell K, Fontana IC, Franzmeier N, Frost B, Horie K, Kaňovský P, Kao AW, Mahinrad S, Malpetti M, Morris HR, Palleis C, Petrucelli L, Rexach J, Reyderman L, Rommel A, Rowe JB, Sanabria Bohórquez SM, Sato C, Schöll M, Schneider A, de Silva R, Snyder HM, VandeVrede L, Varga AW, Vogel JW, Yeh FL, Yoo AS, Carrillo MC.   +41 more
europepmc   +1 more source

Tau conformation, distribution and PET imaging correlations in progressive supranuclear palsy. [PDF]

Transl Neurodegener
Dong C, Ma JH, Qiao HW, Tamagnan GD, Chan P, Liu SY.   +5 more
europepmc   +1 more source

Clinicopathological features of primary tauopathies: a brain bank series. [PDF]

Front Neurol
Ryan B, Marriott L, Murray H, Faull RLM, Turner CP, Curtis MA.   +5 more
europepmc   +1 more source

Elucidating the Neurobiological Underpinnings of Mild Behavioral Impairment in Tauopathies: Clinical and Molecular Insights. [PDF]

Int J Mol Sci
Angelopoulou E, Papatriantafyllou J, Papageorgiou S, Villa C.   +3 more
europepmc   +1 more source